STTK

Shattuck Labs (STTK)

About Shattuck Labs (STTK)

Shattuck Labs, Inc. is a biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Details

Daily high
$3.86
Daily low
$3.54
Price at open
$3.54
52 Week High
$4.89
52 Week Low
$0.69
Market cap
238.6M
Dividend yield
0.00%
Volume
419,447
Avg. volume
761,934
P/E ratio
-3.70

Shattuck Labs News

Details

Daily high
$3.86
Daily low
$3.54
Price at open
$3.54
52 Week High
$4.89
52 Week Low
$0.69
Market cap
238.6M
Dividend yield
0.00%
Volume
419,447
Avg. volume
761,934
P/E ratio
-3.70